PharmExec Direct:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
August 4, 2011 | ISSUE NUMBER 211 VOL 8


Economy
Pharma Leads the Pack in July Job Losses
Springtime optimism and the gentle steam of a perceived economic recovery in the US has all but dissipated, with the blanketing heat of deficit politics and a job situation that's anything but August. In July, the pharmaceutical industry shed 13,493 jobs, more than any other sector, according to a Challenger, Gray & Christmas report ...Read more

Product Launch
AstraZeneca's Orphan Challenge
In an exclusive interview with Pharm Exec, AstraZeneca’s Executive Director of Oncology Eric Vogul outlines some of the challenges—from establishing patient population size to finding a name—the company faced in launching Caprelsa, its very first orphan drug ...Read More

R&D
Pharma/Academic Partnerships for Drug Development
In this episode of Pharma Faceoff, Ken Kaitin, Director and Research Professor at the Tufts Center for the Study of Drug Development, talks about the potential benefits of pharma/academic center partnerships for developing new drugs
...Click to Watch

Advertisement
CBI's 14th Registries and Post-Approval Studies Congress — September 20-22, 2011, Philadelphia, PA
Discover why industry leaders have trusted CBI’s Post-Approval Series for more than a decade!Attend the Post-Approval event of the year and hear perspectives from Celgene, Covidien, FDA, Forest, Health Canada, Ironwood Pharmaceuticals, Merck, NIH, Pfizer, Takeda Europe and more. Register at www.cbinet.com/postapproval by August 31 and save $500 with priority code HYH467.

Regulatory
FDA Pledges Better CDER Communication
A new FDA report highlights labels, emergency communication, and risk communication as three keys areas in need of improvement at the Center for Drug Evaluation and Research, and pledges to prioritize them in the coming months ...Read more

Advertisement
Join the Pharma Faceoff debate. Can the iPad really transform the pharma industry or is it a tech fad that will burst like the dot-com bubble?
www.pharmafaceoff.com/episodes/can-the-ipad-save-sales

// MTI (Langhorne, Pa.) appointed Kyu Om as Vice President, Business Development. // James R. Largent joined the Board of Directors of Alimera Sciences (Alpharetta, Ga.). // Mark Sneff was named Vice President, Human Resources, at Premier Research Group (Philadelphia). // Ogilvy CommonHealth Worldwide (Parsippany, NJ) promoted Colleen Briggs to Senior Partner, Head of Planning. The company also hired Jeff Bratteson as Creative Director and Ken Gotschall as Vice President, Finance.

Sept. 15–16: Life Sciences Commercial IT Summit
Philadelphia, PA

Sept. 20–21: Strategic Pipeline Planning and Resource Allocation Summit
Philadelphia, PA

Sept. 26–27: Pharma/Bio Forum on Preclinical Development
Boston, MA


Oct. 14: L2 Clinic: The Social Graph: Pharma
New York, NY


 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook

 
Survey
If you were developing a biosimilar product, what would be your biggest concern?
Click To Vote
 
Quick Links

Flu Vaccine Production to Double by 2015

Read the New Pharm Exec Global Digest

10 Pitfalls of Pharma Licensing Agreements


 
User Management
| Subscribe | Update My Profile | Advertise With Us | Visit PharmExec.com |

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

 
Visit Pharmaceutical Executive